Sat.Mar 29, 2025 - Fri.Apr 04, 2025

article thumbnail

Cell, gene therapy makers lose a champion at FDA with exit of Peter Marks

BioPharma Drive: Drug Pricing

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Therapies 283
article thumbnail

More Type 1 Diabetics Are Obese, Taking GLP-1 Drugs

Drugs.com

MONDAY, March 31, 2025 -- Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says.Both adults and children with type 1.

Drugs 276
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Highly accurate blood test diagnoses Alzheimer's disease, measures extent of dementia

Science Daily: Pharmacology News

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a new study.

Disease 270
article thumbnail

Keystone Symposia Aims to Increase Global Impact-- Experts Weigh in on Strategy

keypoint

Keystone Symposia convened a panel of global health experts to discuss how, as a conference organization, we can extend the reach and impact of our conferences to improve human health worldwide.

69
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Peter Marks, FDA’s top vaccine official, resigns

BioPharma Drive: Drug Pricing

In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed “misinformation and lies.

Vaccine 298

More Trending

article thumbnail

New study links lower proportions of certain sleep stages to brain changes associated with Alzheimer's disease

Science Daily: Pharmacology News

New research reveals that lower proportions of specific sleep stages are associated with reduced brain volume in regions vulnerable to the development of Alzheimer's disease over time.

Disease 186
article thumbnail

The Nobel Duel

Codon

A cautionary tale about the competitive pressures of scientific research, and how they alter the course of history.

article thumbnail

How discoverable, comparable and explorable is your data?

BioPharma Drive: Drug Pricing

Accelerate biomarker research with high-quality, expert-curated data to drive precision medicine.

Research 246
article thumbnail

Citrus Oil Formula May Relieve Dry Mouth for Cancer Patients

Drugs.com

SATURDAY, March 29, 2025 -- A new formula made with natural citrus oil could help cancer patients find relief from dry mouth, a common and painful side effect of radiation treatments.The formula was created by researchers at the University of South.

Research 240
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Discovery of Quina technology challenges view of ancient human development in East Asia

Science Daily: Pharmacology News

Researchers have uncovered a complete Quina technological system in the Longtan site in southwest China. The discovery challenges the widely held perception that the Middle Paleolithic period was mostly static in East Asia.

Research 179
article thumbnail

Project Optimus: Transforming Dose Optimization in Oncology Drug Development

Fierce BioTech

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how sponsors can align with FDA expectations and implement more precise dose-finding strategies. Watch the full interview with Alex MacDonald now!

article thumbnail

FDA official’s ouster sends shares of vaccine makers sliding

BioPharma Drive: Drug Pricing

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews vaccines, resigned on Friday.

Vaccine 230
article thumbnail

Bad Sleep Linked To Alzheimer's-Related Brain Changes

Drugs.com

MONDAY, March 31, 2025 -- Certain stages of sleep deep sleep and dream sleep appear to contribute to brain health in ways that affect risk of Alzheimers disease, a new study says.People who get less deep sleep or dream sleep have smaller volum.

Disease 214
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Mpox could become a serious global threat, scientists warn

Science Daily: Pharmacology News

Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists.

161
161
article thumbnail

Aarti Krishnan

Broad Institute

James J. Collins Research Group at MIT - The Collins lab focuses on synthetic biology and systems biology, with an emphasis on infectious diseases and antibiotic resistance.

Disease 52
article thumbnail

HHS begins layoffs in chaotic fashion

BioPharma Drive: Drug Pricing

Reduction-in-force notices went out Tuesday morning to employees across HHS. At FDA, OND director Peter Stein is departing as cuts hit CDER.

FDA 164
article thumbnail

New Drug May Cut Sudden Heart Risk by 94%

Drugs.com

MONDAY, March 31, 2025 -- A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk factor in the blood.The drug, made by Eli Lilly and called lepodisiran, lowered levels of a tiny particle called.

Drugs 165
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Martian dust could pose health risks to future astronauts

Science Daily: Pharmacology News

Inhaling dust particles from the Red Planet over long periods of time could put humans at risk of developing respiratory issues, thyroid disease and other health problems.

Disease 168
article thumbnail

Five critical challenges awaiting Marty Makary

Agency IQ

By Alexander Gaffney, MS, RAC MARTY MAKARY has been confirmed by the Senate as the next commissioner of the FDA. But Makary will almost immediately face challenges that will make his tenure as commissioner especially difficult. Here, AgencyIQ identifies and explores five of the biggest hurdles the new commissioner will face. Fill out the form to read the full article.

FDA 52
article thumbnail

RNA editing biotech Airna adds $155M in funding

BioPharma Drive: Drug Pricing

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

RNA 148
article thumbnail

Experts Concerned as NIH Axes Critical Vaccine Study Funds

Drugs.com

TUESDAY, April 1, 2025 -- Hundreds of U.S. research projects aimed at boosting vaccine confidence have been shut down -- just as preventable diseases like measles and flu are on the rise. Since Jan. 20, the U.S. Department of Health and Human.

147
147
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

New warnings of a 'Butterfly Effect' -- in reverse

Science Daily: Pharmacology News

A new study warns that global climate change may have a devastating effect on butterflies, turning their species-rich, mountain habitats from refuges into traps. Think of it as the 'butterfly effect' -- the idea that something as small as the flapping of a butterfly's wings can eventually lead to a major event such as a hurricane -- in reverse. The new study also suggests that a lack of comprehensive global data about insects may leave conservationists and policymakers ill-prepared to mitigate b

161
161
article thumbnail

Navigating the Transition from ICH E6 (R2) to (R3)

thought leadership

Ensuring Compliance with ProPharma's Expert Support The global regulatory landscape for clinical trials continues to evolve to keep pace with technological advancements, risk management, and the increasing complexity of clinical research.

article thumbnail

Judge overturns FDA’s lab developed test regulation, siding with industry

BioPharma Drive: Drug Pricing

A Texas judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.

article thumbnail

FDA Approves Cabozantinib for Previously Treated Advanced Neuroendocrine Tumors

Drugs.com

MONDAY, March 31, 2025 -- The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced neuroendocrine tumors, offering a new standard of care for this.

article thumbnail

'She loves me, she loves me not': Physical forces encouraged evolution of multicellular life, scientists propose

Science Daily: Pharmacology News

A study presents a striking example of cooperative organization among cells as a potential force in the evolution of multicellular life. The study is based on the fluid dynamics of cooperative feeding by Stentor, a relatively giant unicellular organism.

161
161